Pneumotox Drug

Time 2020-10-18 17:04:01

Web Name: Pneumotox Drug

WebSite: http://www.pneumotox.com

ID:86271

Keywords:

Pneumotox,Drug,

Description:

I.aw Persistent reduction in diffusing capacity for CO upon resolution of the adverse effect II.u Acute respiratory failure (ARDS, pulmonary edema, severe bronchospasm) requiring ECMO X.e Autoimmunity - Autoimmune conditions (+ANA, +anti-ds-DNA, +ANCAs, other auto-Abs) XV.i Path: Pneumocyte atypia (reactive epithelial cells) (a.k.a. the "Napoleon Hat" sign) XV.ay Path: Smoking-related interstitial fibrosis (SRIF). Respiratory bronchiolitis with fibrosis XV.bn Path: Silicone droplets/vacuoles in lung tissue, pulmonary vasculature, or lymph nodes XVI.i Imaging: An area or areas of involvement with a recognizable anatomic distribution XVI.s Imaging: An area or areas of involvement with high attenuation numbers or metallic density XVI.aa Imaging: Nodules, mass or masses with a central area of low attenuation (see also under XVIaa) XVI.ab Imaging: Cavitating lung nodule, mass or nodules (see also Iq, XIs, XIIi, XVIaa and XVIIp) XVI.ae Imaging: A pattern similar to pneumoconiotic progressive massive fibrosis (PMF) XVI.bj Imaging: Atelectasis (a combination of increased density and volume loss. Typically lobar) XVI.bl Imaging: An area or areas of avid tracer uptake in the lung/chest on 18F-PET scan XVIII.b Eye catcher: Electron-dense area or areas of consolidation on unenhanced chest CT XVIII.t Eye catcher: Purpuric/Ecchymotic/Cyanotic lesions of the earlobes and/or nose XIX.i BAL: Oil red O-stainable material in BAL macrophages othen than exogenous lipids The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy. Learn more about cookies

TAGS:Pneumotox Drug 

<<< Thank you for your visit >>>

Hot Websites